Research To Practice | Oncology Videos
By Dr Neil Love
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Dr Neil Love
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 69
Reviews: 0
Episodes: 790
Description
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
| Episode | Date |
|---|---|
|
Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
|
Dec 13, 2025 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
|
Dec 12, 2025 |
|
Lung Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
|
Dec 12, 2025 |
|
CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
|
Dec 11, 2025 |
|
HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach
|
Dec 10, 2025 |
|
HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach (Companion Faculty Lecture)
|
Dec 09, 2025 |
|
Breast Cancer — Highlights from the 2025 ESMO Annual Meeting
|
Dec 08, 2025 |
|
Breast Cancer — Microlearning Activity 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
|
Dec 05, 2025 |
|
Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
|
Dec 04, 2025 |
|
Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning (Companion Faculty Lecture)
|
Dec 04, 2025 |
|
Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
|
Dec 02, 2025 |
|
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
|
Nov 29, 2025 |
|
Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates
|
Nov 26, 2025 |
|
HER2-Positive Gastrointestinal Cancers — Clinical Investigator Perspectives on Actual Patient Cases
|
Nov 21, 2025 |
|
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
|
Nov 20, 2025 |
|
HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders (Companion Faculty Lecture)
|
Nov 19, 2025 |
|
Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
|
Nov 15, 2025 |
|
ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs
|
Nov 14, 2025 |
|
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Nov 13, 2025 |
|
Colorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Nov 12, 2025 |
|
Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Nov 11, 2025 |
|
Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Nov 10, 2025 |
|
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Nov 07, 2025 |
|
Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient Cases
|
Nov 06, 2025 |
|
ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders
|
Nov 05, 2025 |
|
ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders (Companion Faculty Lecture)
|
Nov 03, 2025 |
|
Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis
|
Oct 30, 2025 |
|
Colorectal Cancer — An Interview with Dr John Strickler on Molecular Residual Disease Analysis (Companion Faculty Lecture)
|
Oct 29, 2025 |
|
Breast Cancer — 5-Minute Journal Club Issue 4 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Oct 24, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA
|
Oct 23, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA (Companion Faculty Lecture)
|
Oct 22, 2025 |
|
Metastatic Breast Cancer — Current and Future Integration of Antibody-Drug Conjugates
|
Oct 21, 2025 |
|
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Oct 20, 2025 |
|
Non-Hodgkin Lymphoma — The Implications of Recent Datasets for Current and Future Disease Management
|
Oct 18, 2025 |
|
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
|
Oct 14, 2025 |
|
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment (Companion Faculty Lecture)
|
Oct 13, 2025 |
|
Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
|
Oct 10, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors
|
Oct 09, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors (Companion Faculty Lecture)
|
Oct 08, 2025 |
|
Breast Cancer — An ASCO 2025 Review
|
Oct 07, 2025 |
|
Breast Cancer — An ASCO 2025 Review (Faculty Case Presentations)
|
Oct 06, 2025 |
|
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
|
Oct 02, 2025 |
|
Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Sep 26, 2025 |
|
Metastatic BRCA-Negative Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management
|
Sep 23, 2025 |
|
Metastatic BRCA-Negative, Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management (Companion Faculty Lecture)
|
Sep 22, 2025 |
|
Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management
|
Sep 21, 2025 |
|
Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy
|
Sep 20, 2025 |
|
Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)
|
Sep 19, 2025 |
|
Metastatic Triple-Negative Breast Cancer — The Selection and Sequencing of Therapy
|
Sep 17, 2025 |
|
Ocular Toxicities Associated with ADCs and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management
|
Sep 16, 2025 |
|
Ocular Toxicities Associated with ADCs and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management
|
Sep 15, 2025 |
|
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Sep 12, 2025 |
|
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 1
|
Sep 08, 2025 |
|
Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason on Optimizing Patient Care
|
Sep 06, 2025 |
|
Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier Leleu
|
Sep 05, 2025 |
|
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Sep 01, 2025 |
|
Relapsed/Refractory Multiple Myeloma — Oncology Q&A: Discussing Common Questions Posed by Patients
|
Aug 29, 2025 |
|
Biliary Tract Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2
|
Aug 28, 2025 |
|
Brain Metastases with HER2-Positive Breast Cancer — An Interview with Dr Sarah Sammons on Optimal Management Approaches
|
Aug 26, 2025 |
|
Brain Metastases with HER2-Positive Breast Cancer — An Interview with Dr Sarah Sammons on Optimal Management Approaches (Companion Faculty Lecture)
|
Aug 25, 2025 |
|
Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases
|
Aug 22, 2025 |
|
Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm
|
Aug 20, 2025 |
|
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Aug 15, 2025 |
|
Multiple Myeloma | Oncology Q&A for Patients: Clinical Experts Address Common Questions Posed by Patients with Relapsed/Refractory Multiple Myeloma
|
Aug 15, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations
|
Aug 12, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations (Companion Faculty Lecture)
|
Aug 11, 2025 |
|
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Aug 08, 2025 |
|
Multiple Myeloma — Optimizing the Selection of First-Line Therapy
|
Aug 07, 2025 |
|
Multiple Myeloma | Peter Voorhees, MD
|
Aug 06, 2025 |
|
Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
|
Aug 03, 2025 |
|
Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances
|
Aug 02, 2025 |
|
Endometrial and Cervical Cancer | Susana Banerjee, MBBS, MA, PhD
|
Aug 01, 2025 |
|
Ovarian Cancer | Ursula Matulonis, MD
|
Jul 31, 2025 |
|
Oncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care
|
Jul 30, 2025 |
|
Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management
|
Jul 29, 2025 |
|
Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management (Companion Faculty Lecture)
|
Jul 28, 2025 |
|
Soft Tissue Sarcoma and Other Connective Tissue Neoplasms — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
|
Jul 24, 2025 |
|
Renal Cell Carcinoma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
|
Jul 23, 2025 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
|
Jul 21, 2025 |
|
Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches
|
Jul 18, 2025 |
|
Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
|
Jul 17, 2025 |
|
Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates
|
Jul 16, 2025 |
|
HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 14, 2025 |
|
For Oncology Nurses: Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress
|
Jul 11, 2025 |
|
Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 10, 2025 |
|
Non-Hodgkin Lymphoma — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 09, 2025 |
|
For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jul 07, 2025 |
|
For Oncology Nurses: Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress
|
Jul 05, 2025 |
|
Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 03, 2025 |
|
Colorectal Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 02, 2025 |
|
Ovarian and Endometrial Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jun 30, 2025 |
|
For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress
|
Jun 27, 2025 |
|
Prostate Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jun 25, 2025 |
|
IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies
|
Jun 24, 2025 |
|
IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies (Companion Faculty Lecture)
|
Jun 23, 2025 |
|
EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jun 20, 2025 |
|
Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 1 of 2
|
Jun 19, 2025 |
|
Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
|
Jun 18, 2025 |
|
Multiple Myeloma | Meletios-Athanasios (Thanos) C Dimopoulos, MD
|
Jun 17, 2025 |
|
Multiple Myeloma | Robert Z Orlowski, MD, PhD
|
Jun 17, 2025 |
|
For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jun 16, 2025 |
|
Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances
|
Jun 13, 2025 |
|
Myelofibrosis | John Mascarenhas, MD
|
Jun 12, 2025 |
|
Myelofibrosis | Professor Claire Harrison
|
Jun 12, 2025 |
|
For Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jun 11, 2025 |
|
Non-Small Cell Lung Cancer and Therapeutic Targets Beyond EGFR — Year in Review Series on Relevant New Datasets and Advances
|
Jun 10, 2025 |
|
Non-Small Cell Lung Cancer | Joel W Neal, MD, PhD
|
Jun 08, 2025 |
|
Non-Small Cell Lung Cancer | Jessica J Lin, MD
|
Jun 08, 2025 |
|
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress
|
Jun 07, 2025 |
|
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
|
Jun 06, 2025 |
|
Non-Hodgkin Lymphoma | Stephen M Ansell, MD, PhD
|
Jun 05, 2025 |
|
Non-Hodgkin Lymphoma | Brian T Hill, MD, PhD
|
Jun 05, 2025 |
|
Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances
|
Jun 04, 2025 |
|
Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting
|
Jun 03, 2025 |
|
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
|
Jun 02, 2025 |
|
Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit
|
Jun 01, 2025 |
|
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
|
May 31, 2025 |
|
For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress
|
May 30, 2025 |
|
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
May 29, 2025 |
|
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)
|
May 29, 2025 |
|
5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
May 27, 2025 |
|
Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit
|
May 26, 2025 |
|
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
May 25, 2025 |
|
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)
|
May 24, 2025 |
|
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
|
May 23, 2025 |
|
Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit
|
May 22, 2025 |
|
Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit
|
May 21, 2025 |
|
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
|
May 20, 2025 |
|
5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
May 19, 2025 |
|
Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit
|
May 18, 2025 |
|
Colorectal Cancer — Fourth Annual National General Medical Oncology Summit
|
May 17, 2025 |
|
Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy
|
May 16, 2025 |
|
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
|
May 15, 2025 |
|
Prostate Cancer | Emmanuel S Antonarakis, MD
|
May 14, 2025 |
|
Prostate Cancer | Professor Karim Fizazi, MD, PhD
|
May 13, 2025 |
|
Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit
|
May 12, 2025 |
|
Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit
|
May 11, 2025 |
|
Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
May 10, 2025 |
|
Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)
|
May 09, 2025 |
|
For Oncology Nurses: Prostate Cancer — Proceedings from the 2025 Annual ONS Congress
|
May 08, 2025 |
|
Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
|
May 07, 2025 |
|
Breast Cancer | Nancy U Lin, MD
|
May 06, 2025 |
|
Breast Cancer | Rebecca A Dent, MD, MSc
|
May 06, 2025 |
|
Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
|
May 04, 2025 |
|
Chronic Lymphocytic Leukemia | Jennifer R Brown, MD, PhD
|
May 03, 2025 |
|
Chronic Lymphocytic Leukemia | Paolo Ghia, MD, PhD
|
May 03, 2025 |
|
For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress
|
May 01, 2025 |
|
Prostate Cancer — Fourth Annual National General Medical Oncology Summit
|
Apr 29, 2025 |
|
Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies
|
Apr 29, 2025 |
|
Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit
|
Apr 27, 2025 |
|
For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress
|
Apr 26, 2025 |
|
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
|
Apr 25, 2025 |
|
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy (Companion Faculty Lecture)
|
Apr 24, 2025 |
|
Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates
|
Apr 23, 2025 |
|
Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies
|
Apr 22, 2025 |
|
EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit
|
Apr 20, 2025 |
|
HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
|
Apr 19, 2025 |
|
Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2
|
Apr 18, 2025 |
|
Ovarian Cancer — Proceedings from a Session Held During the 2025 SGO Annual Meeting on Women's Cancer®
|
Apr 17, 2025 |
|
Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
Apr 16, 2025 |
|
Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)
|
Apr 16, 2025 |
|
Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit
|
Apr 14, 2025 |
|
HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit
|
Apr 13, 2025 |
|
Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit
|
Apr 12, 2025 |
|
Neuroendocrine Tumors — Fourth Annual National General Medical Oncology Summit
|
Apr 11, 2025 |
|
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
|
Apr 10, 2025 |
|
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor (Companion Faculty Lecture)
|
Apr 09, 2025 |
|
Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates
|
Apr 08, 2025 |
|
Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates (Companion Faculty Lecture)
|
Apr 07, 2025 |
|
Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences
|
Apr 05, 2025 |
|
HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 SGO Annual Meeting on Women's Cancer®
|
Apr 03, 2025 |
|
Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel
|
Mar 29, 2025 |
|
Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel (Companion Faculty Lecture)
|
Mar 28, 2025 |
|
HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy
|
Mar 27, 2025 |
|
For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards
|
Mar 24, 2025 |
|
ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Mar 21, 2025 |
|
Oncology Nursing Update: Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig
|
Mar 18, 2025 |
|
Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)
|
Mar 15, 2025 |
|
Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Mar 14, 2025 |
|
Colorectal Cancer | Scott Kopetz, MD, PhD
|
Mar 13, 2025 |
|
Colorectal Cancer | Jeffrey Meyerhardt, MD, MPH
|
Mar 12, 2025 |
|
Localized Breast Cancer — Examining the Current Use of Genetic Testing and Related Clinical Management
|
Mar 11, 2025 |
|
Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)
|
Mar 07, 2025 |
|
5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Mar 03, 2025 |
|
Biliary Tract Cancers — Reviewing Patient Cases with Prof John Bridgewater: Part 1 of 2
|
Mar 01, 2025 |
|
Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies
|
Feb 24, 2025 |
|
Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
|
Feb 21, 2025 |
|
Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy
|
Feb 19, 2025 |
|
Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy (Companion Faculty Lecture)
|
Feb 18, 2025 |
|
HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies
|
Feb 14, 2025 |
|
Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
|
Feb 13, 2025 |
|
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
|
Feb 11, 2025 |
|
EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD
|
Feb 09, 2025 |
|
5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Feb 08, 2025 |
|
EGFR-Mutant Non-Small Cell Lung Cancer | Enriqueta Felip, MD, PhD
|
Feb 07, 2025 |
|
Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani
|
Feb 06, 2025 |
|
Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani (Companion Faculty Lecture)
|
Feb 04, 2025 |
|
5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Jan 31, 2025 |
|
Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series
|
Jan 30, 2025 |
|
Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questions Posed by Patients
|
Jan 24, 2025 |
|
Metastatic Triple-Negative Breast Cancer | Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer
|
Jan 17, 2025 |
|
Lymphoma | What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma
|
Jan 16, 2025 |
|
Myelofibrosis | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Myelofibrosis
|
Jan 14, 2025 |
|
Metastatic Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer
|
Jan 10, 2025 |
|
Chronic Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia
|
Jan 09, 2025 |
|
Acute Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
|
Jan 07, 2025 |
|
Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer
|
Jan 03, 2025 |
|
HER2-Low and HER2-Ultralow Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer
|
Dec 23, 2024 |
|
Multiple Myeloma | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma
|
Dec 21, 2024 |
|
Chronic Lymphocytic Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia
|
Dec 19, 2024 |
|
Colorectal and Gastroesophageal Cancers | Cases from the Community: Integrating New Research Findings into Practice
|
Dec 18, 2024 |
|
Hepatobiliary Cancers | Cases from the Community: Integrating New Research Findings into Practice
|
Dec 18, 2024 |
|
Gynecologic Cancers | Cases from the Community: Integrating New Research Findings into Practice
|
Dec 17, 2024 |
|
Myelofibrosis | Cases from the Community: Integrating New Research Findings into Practice
|
Dec 17, 2024 |
|
ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2
|
Dec 16, 2024 |
|
Leukemia and Myelodysplastic Syndromes | Cases from the Community: Integrating New Research Findings into Practice
|
Dec 13, 2024 |
|
Lung Cancer | Cases from the Community: Integrating New Research Findings into Practice
|
Dec 13, 2024 |
|
Lung Cancer | Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
|
Dec 11, 2024 |
|
Breast Cancer | Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer
|
Dec 05, 2024 |
|
Paroxysmal Nocturnal Hemoglobinuria | Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria
|
Dec 04, 2024 |
|
Paroxysmal Nocturnal Hemoglobinuria | Jamile M Shammo, MD
|
Dec 04, 2024 |
|
ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
|
Nov 26, 2024 |
|
Multiple Myeloma | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
|
Nov 26, 2024 |
|
Lung Cancer | The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences
|
Nov 25, 2024 |
|
Chronic Lymphocytic Leukemia | Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series
|
Nov 23, 2024 |
|
Tenosynovial Giant Cell Tumor | Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor (Companion Faculty Lecture)
|
Nov 21, 2024 |
|
Tenosynovial Giant Cell Tumor | Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor
|
Nov 21, 2024 |
|
Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
|
Nov 20, 2024 |
|
Prostate Cancer | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
|
Nov 20, 2024 |
|
Hormone Receptor-Positive Metastatic Breast Cancer | Hope S Rugo, MD
|
Nov 19, 2024 |
|
Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
|
Nov 19, 2024 |
|
Lung Cancer | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
|
Nov 16, 2024 |
|
HR-Positive Breast Cancer | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
|
Nov 16, 2024 |
|
Lymphoma | Gilles Salles, MD, PhD
|
Nov 08, 2024 |
|
Lymphoma | What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
|
Nov 08, 2024 |
|
Lung Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences
|
Nov 07, 2024 |
|
Gastrointestinal Cancers | The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review
|
Nov 06, 2024 |
|
Metastatic Breast Cancer | Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
|
Nov 01, 2024 |
|
Mantle Cell Lymphoma | Michael Wang, MD
|
Oct 30, 2024 |
|
Mantle Cell Lymphoma | Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
|
Oct 30, 2024 |
|
HR-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer (Companion Faculty Lecture)
|
Oct 25, 2024 |
|
HR-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
|
Oct 25, 2024 |
|
Chronic Myeloid Leukemia | Jorge Cortes, MD
|
Oct 24, 2024 |
|
Chronic Myeloid Leukemia | Practical Perspectives: Current Management of Chronic Myeloid Leukemia
|
Oct 24, 2024 |
|
Small Cell Lung Cancer | The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
|
Oct 23, 2024 |
|
Desmoid Tumors | Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
|
Oct 18, 2024 |
|
Peripheral T-Cell Lymphoma | Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma (Companion Faculty Lecture)
|
Oct 17, 2024 |
|
Peripheral T-Cell Lymphoma | Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma
|
Oct 17, 2024 |
|
Metastatic Non-Small Cell Lung Cancer | The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
|
Oct 16, 2024 |
|
Chronic Lymphocytic Leukemia | Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
|
Oct 10, 2024 |
|
Diffuse Large B-Cell Lymphoma | Data + Perspectives: Clinical Investigators Discuss the Current and Future Management of Diffuse Large B-Cell Lymphoma
|
Oct 09, 2024 |
|
Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR | The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR
|
Oct 08, 2024 |
|
Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
|
Oct 04, 2024 |
|
Non-Small Cell Lung Cancer with EGFR Mutations | The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations
|
Oct 02, 2024 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Companion Faculty Lecture)
|
Sep 25, 2024 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
|
Sep 25, 2024 |
|
Biliary Tract Cancers | Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
|
Sep 20, 2024 |
|
Neuroendocrine Tumors | Pamela Kunz, MD
|
Sep 19, 2024 |
|
Neuroendocrine Tumors | Simron Singh, MD, MPH
|
Sep 19, 2024 |
|
Neuroendocrine Tumors | Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
|
Sep 19, 2024 |
|
Gastrointestinal Cancers | John Strickler, MD
|
Sep 13, 2024 |
|
Gastrointestinal Cancers | Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
|
Sep 13, 2024 |
|
Gastrointestinal Cancers | Tanios Bekaii-Saab, MD
|
Sep 13, 2024 |
|
Non-Small Cell Lung Cancer with an EGFR Mutation | Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
|
Sep 12, 2024 |
|
Dedifferentiated Liposarcoma | Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma
|
Sep 10, 2024 |
|
HR-Positive and Triple-Negative Metastatic Breast Cancer | Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
|
Sep 06, 2024 |
|
HR-Positive and Triple-Negative Metastatic Breast Cancer | Professor Peter Schmid, FRCP, MD, PhD
|
Sep 06, 2024 |
|
HR-Positive and Triple-Negative Metastatic Breast Cancer | Sara M Tolaney, MD, MPH
|
Sep 06, 2024 |
|
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer (Companion Faculty Lecture)
|
Aug 30, 2024 |
|
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer
|
Aug 30, 2024 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 29, 2024 |
|
Metastatic Breast Cancer | Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
|
Aug 23, 2024 |
|
Ovarian and Endometrial Cancer | Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
|
Aug 22, 2024 |
|
Non-Small Cell Lung Cancer | Professor Solange Peters, MD, PhD
|
Aug 21, 2024 |
|
Non-Small Cell Lung Cancer | Professor Ben Solomon, MBBS, PhD
|
Aug 21, 2024 |
|
Non-Small Cell Lung Cancer | Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
|
Aug 21, 2024 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
|
Aug 16, 2024 |
|
Lung Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer
|
Aug 14, 2024 |
|
Multiple Myeloma | Jesús G Berdeja, MD
|
Aug 12, 2024 |
|
Multiple Myeloma | Thomas Martin, MD
|
Aug 12, 2024 |
|
Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
|
Aug 12, 2024 |
|
Skin Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
|
Aug 09, 2024 |
|
Breast Cancer | Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
|
Aug 07, 2024 |
|
Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
|
Aug 05, 2024 |
|
Prostate Cancer | Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
|
Aug 02, 2024 |
|
HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer
|
Jul 31, 2024 |
|
HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer (Companion Faculty Lecture)
|
Jul 31, 2024 |
|
Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
|
Jul 26, 2024 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
|
Jul 25, 2024 |
|
Melanoma and Nonmelanoma Skin Cancers | Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
|
Jul 19, 2024 |
|
Renal Cell Carcinoma | Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
|
Jul 18, 2024 |
|
Colorectal Cancer | RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
|
Jul 16, 2024 |
|
Lymphoma | RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
|
Jul 12, 2024 |
|
Triple-Negative Breast Cancer | What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
|
Jul 11, 2024 |
|
Multiple Myeloma | Breakfast with the Investigators: New Advances in Multiple Myeloma
|
Jul 09, 2024 |
|
Lung Cancer | Breakfast with the Investigators: Current and Emerging Role of Antibody-Drug Conjugates in the Treatment of Lung Cancer
|
Jul 08, 2024 |
|
Myelofibrosis | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
|
Jul 02, 2024 |
|
Prostate Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Prostate Cancer
|
Jul 01, 2024 |
|
Metastatic Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Metastatic Breast Cancer
|
Jun 28, 2024 |
|
Ovarian and Endometrial Cancer | Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Ovarian and Endometrial Cancer
|
Jun 27, 2024 |
|
Antibody-Drug Conjugates | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Optimal Implementation of Antibody-Drug Conjugates
|
Jun 26, 2024 |
|
Hepatobiliary Cancers | Lunch with the Investigators: Hepatobiliary Cancers
|
Jun 25, 2024 |
|
Non-Small Cell Lung Cancer | Second Opinion: Investigators Discuss How They Apply Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer with an EGFR Mutation
|
Jun 21, 2024 |
|
Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer
|
Jun 20, 2024 |
|
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer'
|
Jun 18, 2024 |
|
Chronic Lymphocytic Leukemia and Lymphoma | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Chronic Lymphocytic Leukemia and Bispecific Antibodies in the Management of Lymphoma
|
Jun 14, 2024 |
|
Breast Cancer | Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
|
Jun 13, 2024 |
|
Non-Small Cell Lung Cancer | Justin F Gainor, MD
|
Jun 12, 2024 |
|
Non-Small Cell Lung Cancer | Karen Reckamp, MD, MS
|
Jun 12, 2024 |
|
Non-Small Cell Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
|
Jun 12, 2024 |
|
Gastroesophageal and Colorectal Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Gastroesophageal and Colorectal Cancers
|
Jun 10, 2024 |
|
Urothelial Bladder Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
|
Jun 07, 2024 |
|
Myelofibrosis | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Myelofibrosis
|
Jun 06, 2024 |
|
Ovarian Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Ovarian Cancer
|
Jun 04, 2024 |
|
Head and Neck Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer
|
May 31, 2024 |
|
Prostate Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Prostate Cancer
|
May 30, 2024 |
|
Lymphoma | Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
|
May 29, 2024 |
|
Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Companion Faculty Lecture)
|
May 28, 2024 |
|
Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
|
May 28, 2024 |
|
Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)
|
May 24, 2024 |
|
Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
|
May 24, 2024 |
|
Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers
|
May 23, 2024 |
|
HER2-Positive Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
|
May 21, 2024 |
|
Endometrial Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Endometrial Cancer
|
May 18, 2024 |
|
Prostate Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Prostate Cancer
|
May 16, 2024 |
|
Acute Myeloid Leukemia | Naval Daver, MD
|
May 14, 2024 |
|
Acute Myeloid Leukemia | Courtney D DiNardo, MD, MSCE
|
May 14, 2024 |
|
Acute Myeloid Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
|
May 14, 2024 |
|
Non-Small Cell Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Non-Small Cell Lung Cancer with an EGFR Mutation
|
May 10, 2024 |
|
Metastatic Triple-Negative Breast Cancer | Virtual Case Library: Metastatic Triple-Negative Breast Cancer
|
May 09, 2024 |
|
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
|
May 07, 2024 |
|
Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer (Companion Faculty Lecture)
|
May 03, 2024 |
|
Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
|
May 03, 2024 |
|
Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
|
May 02, 2024 |
|
Endometrial Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Endometrial Cancer
|
May 01, 2024 |
|
Paroxysmal Nocturnal Hemoglobinuria | Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
|
Apr 26, 2024 |
|
Prostate Cancer | Oncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
|
Apr 25, 2024 |
|
Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
|
Apr 24, 2024 |
|
Pancreatic Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Colorectal Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Hepatobiliary Cancers | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Gastroesophageal Cancers | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Multiple Myeloma | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Nontargeted Treatments for Lung Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Targeted Therapy for Non-Small Cell Lung Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Prostate Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Urothelial Bladder Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Renal Cell Carcinoma | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Metastatic HER2-Positive and Triple-Negative Breast Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Localized Breast Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Gynecologic Cancers | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Hodgkin and Non-Hodgkin Lymphoma | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
ER-Positive Metastatic Breast Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
|
Ovarian Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Ovarian Cancer
|
Apr 17, 2024 |
|
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition (Companion Faculty Lecture)
|
Apr 16, 2024 |
|
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
|
Apr 16, 2024 |
|
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
|
Apr 12, 2024 |
|
Colorectal Cancer | Arvind Dasari, MD, MS
|
Apr 08, 2024 |
|
Colorectal Cancer | Thierry André, MD
|
Apr 08, 2024 |
|
Colorectal Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
|
Apr 08, 2024 |
|
Urothelial Bladder Cancer | Thomas Powles, MBBS, MRCP, MD
|
Apr 05, 2024 |
|
Urothelial Bladder Cancer | Shilpa Gupta, MD
|
Apr 05, 2024 |
|
Urothelial Bladder Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
|
Apr 05, 2024 |
|
B7-H3-Targeted Antibody-Drug Conjugates | Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
|
Apr 04, 2024 |
|
Prostate Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
|
Mar 28, 2024 |
|
Prostate Cancer | Andrew J Armstrong, MD, ScM
|
Mar 28, 2024 |
|
Prostate Cancer | Maha Hussain, MD, FACP, FASCO
|
Mar 28, 2024 |
|
Lymphoma | Andrew M Evens, DO, MBA, MSc
|
Mar 27, 2024 |
|
Lymphoma | Sonali M Smith, MD
|
Mar 27, 2024 |
|
Lymphoma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
|
Mar 27, 2024 |
|
ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
|
Mar 26, 2024 |
|
Hepatobiliary Cancers | Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
|
Mar 21, 2024 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
|
Mar 20, 2024 |
|
HER2-Positive and Triple-Negative Breast Cancer | Priyanka Sharma, MD
|
Mar 15, 2024 |
|
HER2-Positive and Triple-Negative Breast Cancer | Ian E Krop, MD, PhD
|
Mar 15, 2024 |
|
HER2-Positive and Triple-Negative Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
|
Mar 15, 2024 |
|
Metastatic Urothelial Bladder Cancer | Virtual Case Library: Metastatic Urothelial Bladder Cancer
|
Mar 13, 2024 |
|
ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer (Companion Faculty Lecture)
|
Mar 11, 2024 |
|
ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
|
Mar 11, 2024 |
|
Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
|
Mar 08, 2024 |
|
Gastroesophageal Cancers | Yelena Y Janjigian, MD
|
Mar 07, 2024 |
|
Gastroesophageal Cancers | Zev Wainberg, MD, MSc
|
Mar 07, 2024 |
|
Gastroesophageal Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
|
Mar 07, 2024 |
|
Chronic Lymphocytic Leukemia | Jeff Sharman, MD
|
Feb 27, 2024 |
|
Chronic Lymphocytic Leukemia | Lindsey Roeker, MD
|
Feb 27, 2024 |
|
Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
|
Feb 27, 2024 |
|
Hepatobiliary Cancers | Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
|
Feb 23, 2024 |
|
Prostate Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer
|
Feb 20, 2024 |
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series
|
Feb 16, 2024 |
|
Colorectal Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer
|
Feb 15, 2024 |
|
Urothelial Bladder Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Urothelial Bladder Cancer
|
Feb 09, 2024 |
|
Gastroesophageal Cancers | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Gastroesophageal Cancers
|
Feb 07, 2024 |
|
Hormone Receptor-Positive Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
|
Feb 01, 2024 |
|
Hormone Receptor-Positive Breast Cancer | Erica Mayer, MD, MPH, FASCO
|
Feb 01, 2024 |
|
Hormone Receptor-Positive Breast Cancer | Stephanie L Graff, MD, FACP
|
Feb 01, 2024 |
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
|
Jan 24, 2024 |
|
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
|
Jan 17, 2024 |
|
Multiple Myeloma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Multiple Myeloma
|
Jan 10, 2024 |
|
Diffuse Large B-Cell Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma
|
Jan 08, 2024 |
|
HER2-Low Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast Cancer
|
Jan 04, 2024 |
|
Chronic Lymphocytic Leukemia | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Chronic Lymphocytic Leukemia
|
Jan 03, 2024 |
|
HER2-Negative Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Localized HER2-Negative Breast Cancer
|
Dec 28, 2023 |
|
Follicular, Mantle Cell and Hodgkin Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Follicular, Mantle Cell and Hodgkin Lymphoma
|
Dec 27, 2023 |
|
ER-Positive Metastatic Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer
|
Dec 21, 2023 |
|
Gynecologic Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
|
Dec 20, 2023 |
|
Biliary Tract Cancer | Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
|
Dec 14, 2023 |
|
Biliary Tract Cancer | Milind Javle, MD
|
Dec 14, 2023 |
|
Biliary Tract Cancer | Lipika Goyal, MD, MPhil
|
Dec 14, 2023 |
|
Lung Cancer | Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
|
Dec 11, 2023 |
|
Non-Small Cell Lung Cancer | Aaron Lisberg, MD
|
Dec 11, 2023 |
|
Non-Small Cell Lung Cancer | Luis Paz-Ares, MD, PhD
|
Dec 11, 2023 |
|
Non-Small Cell Lung Cancer | Zofia Piotrowska, MD, MHS
|
Dec 11, 2023 |
|
Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
|
Dec 06, 2023 |
|
Breast Cancer | Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
|
Nov 30, 2023 |
|
Gynecologic Cancers | Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers
|
Nov 21, 2023 |
|
Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
|
Nov 15, 2023 |
|
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
|
Nov 10, 2023 |
|
HER2-Positive and Triple-Negative Breast Cancer | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
|
Multiple Myeloma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
|
Gynecologic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
|
Hepatobiliary and Pancreatic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
|
Urothelial Bladder Cancer and Renal Cell Carcinoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
|
Lymphoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
|
Nov 02, 2023 |
|
Chronic Lymphocytic Leukemia | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
|
Colorectal and Gastroesophageal Cancers | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
|
Non-Small Cell Lung Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
|
Prostate Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
|
ER-Positive Breast Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
|
Diffuse Large B-Cell Lymphoma | Cases from the Community: Investigators Discuss the Application of Available Research in the Care of Patients with Diffuse Large B-Cell Lymphoma
|
Oct 26, 2023 |
|
Nonmelanoma Skin Cancer | Nikhil I Khushalani, MD
|
Oct 25, 2023 |
|
Nonmelanoma Skin Cancer | Anna C Pavlick, DO, MBA
|
Oct 25, 2023 |
|
Nonmelanoma Skin Cancer | Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer
|
Oct 25, 2023 |
|
Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
|
Oct 23, 2023 |
|
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
|
Oct 20, 2023 |
|
Mantle Cell Lymphoma | What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
|
Oct 19, 2023 |
|
Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
|
Oct 18, 2023 |
|
Lung Cancer | John V Heymach, MD, PhD
|
Oct 16, 2023 |
|
Lung Cancer | Jamie E Chaft, MD
|
Oct 16, 2023 |
|
Lung Cancer | Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
|
Oct 16, 2023 |
|
Pancreatic Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian
|
Oct 13, 2023 |
|
Non-Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
|
Oct 12, 2023 |
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
|
Oct 10, 2023 |
|
Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)
|
Oct 09, 2023 |
|
Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
|
Oct 09, 2023 |
|
Colorectal Cancer | Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
|
Oct 06, 2023 |
|
Colorectal Cancer | J Randolph Hecht, MD
|
Oct 06, 2023 |
|
Colorectal Cancer | Kristen K Ciombor, MD, MSCI
|
Oct 06, 2023 |
|
Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Oct 05, 2023 |
|
Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm (Companion Faculty Lecture)
|
Oct 05, 2023 |
|
Myelofibrosis | Consensus or Controversy? Documenting and Discussing Clinical Investigators' Practice Patterns in Myelofibrosis
|
Oct 04, 2023 |
|
Breast Cancer | Hope S Rugo, MD
|
Sep 29, 2023 |
|
Breast Cancer | Tiffany A Traina, MD, FASCO
|
Sep 29, 2023 |
|
Breast Cancer | Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
|
Sep 29, 2023 |
|
Multiple Myeloma | Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
|
Sep 28, 2023 |
|
Multiple Myeloma | Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma (Companion Faculty Lecture)
|
Sep 28, 2023 |
|
Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer
|
Sep 26, 2023 |
|
Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer (Companion Faculty Lecture)
|
Sep 26, 2023 |
|
Hematologic Oncology | What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
|
Sep 22, 2023 |
|
Pancreatic Cancer | Zev Wainberg, MD, MSc
|
Sep 18, 2023 |
|
Pancreatic Cancer | Eileen M O'Reilly, MD
|
Sep 18, 2023 |
|
Pancreatic Cancer | Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer
|
Sep 18, 2023 |
|
Non-Hodgkin Lymphoma | Martin Hutchings, MD, PhD
|
Sep 14, 2023 |
|
Non-Hodgkin Lymphoma | Loretta J Nastoupil, MD
|
Sep 14, 2023 |
|
Non-Hodgkin Lymphoma | Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
|
Sep 14, 2023 |
|
Melanoma | Meet The Professor: Optimizing the Management of Melanoma
|
Sep 12, 2023 |
|
Lung Cancer | Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
|
Sep 08, 2023 |
|
Hepatocellular Carcinoma | The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma
|
Sep 06, 2023 |
|
Prostate Cancer | Neal D Shore, MD
|
Sep 01, 2023 |
|
Prostate Cancer | Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer
|
Sep 01, 2023 |
|
Mantle Cell Lymphoma | Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma
|
Aug 31, 2023 |
|
Mantle Cell Lymphoma | Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma (Companion Faculty Lecture)
|
Aug 31, 2023 |
|
Soft Tissue Sarcoma | Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
|
Aug 30, 2023 |
|
Chronic Lymphocytic Leukemia and Lymphoma | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences
|
Aug 29, 2023 |
|
Chronic Lymphocytic Leukemia and Lymphoma | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences (Companion Faculty Lecture)
|
Aug 29, 2023 |
|
Genitourinary Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 25, 2023 |
|
Breast Cancer | Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
|
Aug 24, 2023 |
|
Breast Cancer | Erika Hamilton, MD
|
Aug 24, 2023 |
|
Breast Cancer | Aditya Bardia, MD, MPH
|
Aug 24, 2023 |
|
Multiple Myeloma | Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
|
Aug 23, 2023 |
|
Multiple Myeloma | Hans Lee, MD
|
Aug 23, 2023 |
|
Multiple Myeloma | Saad Zafar Usmani, MD, MBA
|
Aug 23, 2023 |
|
Lung Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 22, 2023 |
|
Lung Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture)
|
Aug 22, 2023 |
|
Melanoma and Nonmelanoma Skin Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
|
Aug 17, 2023 |
|
Melanoma and Nonmelanoma Skin Cancers | Evan J Lipson, MD
|
Aug 17, 2023 |
|
Melanoma and Nonmelanoma Skin Cancers | Omid Hamid, MD
|
Aug 17, 2023 |
|
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture)
|
Aug 16, 2023 |
|
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 16, 2023 |
|
Prostate Cancer | Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer
|
Aug 14, 2023 |
|
Gynecologic Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture)
|
Aug 11, 2023 |
|
Gynecologic Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 11, 2023 |
|
Urothelial Bladder Cancer | Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer
|
Aug 10, 2023 |
|
Urothelial Bladder Cancer | Terence Friedlander, MD
|
Aug 10, 2023 |
|
Urothelial Bladder Cancer | Petros Grivas, MD, PhD
|
Aug 10, 2023 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting on Breast Cancer
|
Aug 08, 2023 |
|
Higher-Risk Myelodysplastic Syndromes | David Sallman, MD
|
Aug 02, 2023 |
|
Higher-Risk Myelodysplastic Syndromes | Guillermo Garcia-Manero, MD
|
Aug 02, 2023 |
|
Higher-Risk Myelodysplastic Syndromes | Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes
|
Aug 02, 2023 |
|
Immune Thrombocytopenia | Oncology Today with Dr Neil Love: Management of Immune Thrombocytopenia (Faculty Lecture)
|
Jul 31, 2023 |
|
Immune Thrombocytopenia | Oncology Today with Dr Neil Love: Management of Immune Thrombocytopenia
|
Jul 31, 2023 |
|
Chronic Lymphocytic Leukemia | What I Tell My Patients: New Treatments and Clinical Trials — Chronic Lymphocytic Leukemia
|
Jul 28, 2023 |
|
Paroxysmal Nocturnal Hemoglobinuria | Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria (Faculty Lecture)
|
Jul 26, 2023 |
|
Paroxysmal Nocturnal Hemoglobinuria | Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria
|
Jul 26, 2023 |
|
Renal Cell Carcinoma | Investigator Perspectives on Available Research Findings and Challenging Questions in Renal Cell Carcinoma
|
Jul 17, 2023 |
|
Endometrial Cancer | The Implications of New Research Findings for the Management of Endometrial Cancer
|
Jul 14, 2023 |
|
Gastroesophageal Cancers | Lunch with the Investigators: Gastroesophageal Cancers
|
Jul 13, 2023 |
|
Prostate Cancer | Second Opinion: Investigators Discuss How They and Their Colleagues Apply Available Clinical Research in the Care of Patients with Prostate Cancer
|
Jul 12, 2023 |
|
Hodgkin and Non-Hodgkin Lymphoma | Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma
|
Jul 10, 2023 |
|
Colorectal and Gastroesophageal Cancers | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Colorectal and Gastroesophageal Cancers
|
Jul 07, 2023 |
|
Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma | Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma
|
Jul 05, 2023 |
|
Urothelial Bladder Cancer | Breakfast with the Investigators: Urothelial Bladder Cancer
|
Jun 30, 2023 |
|
Hepatobiliary Cancers | Breakfast with the Investigators: Hepatobiliary Cancers
|
Jun 29, 2023 |
|
Ovarian Cancer | Breakfast with the Investigators: Ovarian Cancer
|
Jun 27, 2023 |
|
Video Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Breast Cancer
|
Jun 26, 2023 |
|
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Urothelial Bladder Cancer
|
Jun 22, 2023 |
|
What I Tell My Patients: Faculty Physicians and Nurses Discuss the Role of Antibody-Drug Conjugates in the Management of HER2-Expressing Cancers Across the Oncology Spectrum
|
Jun 21, 2023 |
|
Video Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Non-Small Cell Lung Cancer
|
Jun 20, 2023 |
|
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Diffuse Large B-Cell Lymphoma
|
Jun 19, 2023 |
|
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part Series
|
Jun 16, 2023 |
|
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Acute Myeloid Leukemia, Myelodysplastic Syndromes and Myelofibrosis
|
Jun 15, 2023 |
|
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Prostate Cancer
|
Jun 12, 2023 |
|
Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 3 of a 3-Part Series
|
Jun 08, 2023 |
|
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Ovarian Cancer
|
Jun 06, 2023 |
|
Oncology Today with Dr Neil Love — HER2-Positive Metastatic Breast Cancer
|
Jun 01, 2023 |
|
Urothelial Bladder Cancer | Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Urothelial Bladder Cancer
|
May 31, 2023 |
|
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Hepatobiliary Cancers
|
May 30, 2023 |
|
Chronic Lymphocytic Leukemia | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Chronic Lymphocytic Leukemia
|
May 25, 2023 |
|
Prostate Cancer | Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Prostate Cancer
|
May 24, 2023 |
|
Lung Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Lung Cancer
|
May 22, 2023 |
|
Biliary Tract Cancers — Richard S Finn, MD
|
May 19, 2023 |
|
Hepatobiliary Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers
|
May 19, 2023 |
|
Hepatocellular Carcinoma — Ghassan Abou-Alfa, MD, MBA
|
May 19, 2023 |
|
Breast Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Breast Cancer
|
May 17, 2023 |
|
Cervical and Endometrial Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Cervical and Endometrial Cancer
|
May 11, 2023 |
|
Colorectal Cancer | Pashtoon M Kasi, MD, MS
|
May 09, 2023 |
|
Colorectal Cancer | Wells A Messersmith, MD
|
May 09, 2023 |
|
Colorectal Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
|
May 09, 2023 |
|
Prostate Cancer | Oncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU Activity
|
May 05, 2023 |
|
Prostate Cancer | Daniel P Petrylak, MD
|
May 05, 2023 |
|
Non-Small Cell Lung Cancer | Luis Paz-Ares, MD, PhD
|
May 01, 2023 |
|
Non-Small Cell Lung Cancer | Heather Wakelee, MD
|
May 01, 2023 |
|
Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
|
May 01, 2023 |
|
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 3
|
Apr 27, 2023 |
|
Endometrial Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Endometrial Cancer
|
Apr 26, 2023 |
|
Myelodysplastic Syndromes | Uma Borate, MD, MS
|
Apr 21, 2023 |
|
Acute Myeloid Leukemia | Andrew H Wei, MBBS, PhD
|
Apr 21, 2023 |
|
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Apr 21, 2023 |
|
Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting — Multiple Myeloma Edition
|
Apr 19, 2023 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer
|
Apr 17, 2023 |
|
Urothelial Bladder Cancer | Matthew Milowsky, MD
|
Apr 17, 2023 |
|
Renal Cell Carcinoma | Thomas Powles, MBBS, MRCP, MD
|
Apr 17, 2023 |
|
Ovarian Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Ovarian Cancer
|
Apr 14, 2023 |
|
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting — Chronic Lymphocytic Leukemia Edition
|
Apr 12, 2023 |
|
Colorectal Cancer | Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 2 of a 3-Part Series
|
Apr 07, 2023 |
|
Prostate Cancer | A Oliver Sartor, MD
|
Apr 06, 2023 |
|
Prostate Cancer | Tanya B Dorff, MD
|
Apr 06, 2023 |
|
Prostate Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
|
Apr 06, 2023 |
|
Gastroesophageal and Hepatobiliary Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal and Hepatobiliary Cancers — A 2023 Post-ASCO GI Webcast
|
Apr 04, 2023 |
|
Hepatobiliary Cancers | Lipika Goyal, MD, MPhil
|
Apr 04, 2023 |
|
Gastroesophageal Cancers | Zev Wainberg, MD, MSc
|
Apr 04, 2023 |
|
Breast Cancer | Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 2 of a 3-Part Series
|
Mar 31, 2023 |
|
Urothelial Bladder Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Urothelial Bladder Cancer
|
Mar 30, 2023 |
|
Prostate Cancer | Investigators Discuss Available Research Guiding the Care of Patients with Prostate Cancer
|
Mar 23, 2023 |
|
Ovarian Cancer and Tumor Treating Fields | Oncology Today with Dr Neil Love — Role of PARP Inhibition in Ovarian Cancer and Recent Data with Tumor Treating Fields
|
Mar 22, 2023 |
|
Hepatobiliary Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Hepatobiliary Cancers
|
Mar 21, 2023 |
|
Lung Cancer | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
|
Gynecologic Cancers | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
|
Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
|
Genitourinary Cancers | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
|
Gastrointestinal Cancers | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
|
Breast Cancer | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
|
Renal Cell Carcinoma | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Renal Cell Carcinoma
|
Mar 16, 2023 |
|
Colorectal Cancer | Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 1 of a 3-Part Series
|
Mar 14, 2023 |
|
Breast Cancer | Ann Partridge, MD, MPH
|
Mar 10, 2023 |
|
Breast Cancer | Kathy Miller, MD
|
Mar 10, 2023 |
|
Breast Cancer | Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
|
Mar 10, 2023 |
|
Gastroesophageal Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal Cancers
|
Mar 07, 2023 |
|
Lung Cancer | Striving for Consensus on the Management of ALK-Positive Lung Cancer
|
Mar 06, 2023 |
|
Lymphomas | Oncology Today with Dr Neil Love: Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting
|
Mar 02, 2023 |
|
Desmoid Tumors | Oncology Today with Dr Neil Love: Management of Desmoid Tumors (Companion Faculty Lecture)
|
Feb 28, 2023 |
|
Desmoid Tumors | Oncology Today with Dr Neil Love: Management of Desmoid Tumors
|
Feb 28, 2023 |
|
ER-Positive and Triple-Negative Breast Cancer | Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series
|
Feb 24, 2023 |
|
BTK Inhibitors | Inside the Issue — Optimizing the Management of Adverse Events Associated with BTK Inhibitors
|
Feb 23, 2023 |
|
Colorectal Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Colorectal Cancer
|
Feb 22, 2023 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer
|
Feb 21, 2023 |
|
Hodgkin and Non-Hodgkin Lymphomas | Laurie H Sehn, MD, MPH
|
Feb 18, 2023 |
|
Hodgkin and Non-Hodgkin Lymphomas | Christopher R Flowers, MD, MS
|
Feb 18, 2023 |
|
Hodgkin and Non-Hodgkin Lymphomas | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas
|
Feb 18, 2023 |
|
Thyroid Cancer and Neuroendocrine Tumors | Oncology Today with Dr Neil Love — Thyroid Cancer and Neuroendocrine Tumors
|
Feb 15, 2023 |
|
Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4
|
Feb 14, 2023 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation (Companion Faculty Lecture)
|
Feb 13, 2023 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation
|
Feb 13, 2023 |
|
Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting
|
Feb 09, 2023 |
|
Gynecologic Oncology | Krishnansu S Tewari, MD
|
Feb 08, 2023 |
|
Gynecologic Oncology | Kathleen N Moore, MD, MS
|
Feb 08, 2023 |
|
Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
|
Feb 08, 2023 |
|
Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma (Companion Faculty Lecture)
|
Feb 06, 2023 |
|
Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma
|
Feb 06, 2023 |
|
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting
|
Feb 02, 2023 |
|
Multiple Myeloma | Ajay K Nooka, MD, MPH
|
Feb 01, 2023 |
|
Multiple Myeloma | Joseph Mikhael, MD, MEd
|
Feb 01, 2023 |
|
Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
|
Feb 01, 2023 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Management of ER-Positive Breast Cancer
|
Jan 31, 2023 |
|
Breast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Metastatic Breast Cancer (Companion Video Lecture)
|
Jan 26, 2023 |
|
Breast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Metastatic Breast Cancer
|
Jan 26, 2023 |
|
Targeted Therapy in Non-Small Cell Lung Cancer | Gregory J Riely, MD, PhD
|
Jan 24, 2023 |
|
Targeted Therapy in Non-Small Cell Lung Cancer | Zofia Piotrowska, MD, MHS
|
Jan 24, 2023 |
|
Targeted Therapy for Non-Small Cell Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
|
Jan 24, 2023 |
|
Chronic Lymphocytic Leukemia | Deborah Stephens, DO
|
Jan 20, 2023 |
|
Chronic Lymphocytic Leukemia | Jennifer R Brown, MD, PhD
|
Jan 20, 2023 |
|
Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
|
Jan 20, 2023 |
|
Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 3
|
Jan 19, 2023 |
|
Breast Cancer | Joyce O'Shaughnessy, MD
|
Jan 17, 2023 |
|
Breast Cancer | Professor Peter Schmid, FRCP, MD, PhD
|
Jan 17, 2023 |
|
Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Breast Cancer
|
Jan 17, 2023 |
|
Acute Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
|
Jan 13, 2023 |
|
Acute Myeloid Leukemia | Courtney D DiNardo, MD, MSCE
|
Jan 13, 2023 |
|
Acute Myeloid Leukemia | Andrew H Wei, MBBS, PhD
|
Jan 13, 2023 |
|
Gastroesophageal Cancers | Oncology Today with Dr Neil Love: Management of Gastroesophageal Cancers (Companion Faculty Lecture)
|
Jan 12, 2023 |
|
Gastroesophageal Cancers | Oncology Today with Dr Neil Love: Management of Gastroesophageal Cancers
|
Jan 12, 2023 |
|
Multiple Myeloma | Addressing Current Questions and Controversies in the Management of Multiple Myeloma — What Clinicians Want to Know
|
Jan 11, 2023 |
|
Hodgkin and Non-Hodgkin Lymphoma | Addressing Current Questions and Controversies in the Management of Hodgkin and Non-Hodgkin Lymphoma — What Clinicians Want to Know
|
Jan 09, 2023 |
|
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder Cancer (Companion Faculty Lecture)
|
Jan 05, 2023 |
|
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder Cancer
|
Jan 05, 2023 |
|
ER-Positive Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of ER-Positive Breast Cancer
|
Jan 04, 2023 |
|
Chronic Lymphocytic Leukemia | Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia — What Clinicians Want to Know
|
Dec 28, 2022 |
|
HER2-Positive Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of HER2-Positive Breast Cancer
|
Dec 22, 2022 |
|
Ovarian Cancer | Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian Cancer (Companion Faculty Lecture)
|
Dec 21, 2022 |
|
Ovarian Cancer | Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian Cancer
|
Dec 21, 2022 |
|
Non-Small Cell Lung Cancer | Alexander I Spira, MD, PhD
|
Dec 16, 2022 |
|
Non-Small Cell Lung Cancer | Helena Yu, MD
|
Dec 16, 2022 |
|
Non‑Small Cell Lung Cancer | Emerging Role of Antibody‑Drug Conjugates in the Management of Non‑Small Cell Lung Cancer
|
Dec 16, 2022 |
|
Multiple Myeloma | BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 2
|
Dec 15, 2022 |
|
Melanoma | Oncology Today with Dr Neil Love: Novel Immunotherapeutic Strategies in Melanoma (Companion Faculty Lecture)
|
Dec 13, 2022 |
|
Melanoma | Oncology Today with Dr Neil Love: Novel Immunotherapeutic Strategies in Melanoma
|
Dec 13, 2022 |
|
Thyroid Cancer | Oncology Today with Dr Neil Love: Thyroid Cancer (Companion Faculty Lecture)
|
Dec 08, 2022 |
|
Thyroid Cancer | Oncology Today with Dr Neil Love: Thyroid Cancer
|
Dec 08, 2022 |
|
Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 2
|
Dec 07, 2022 |
|
Amyloid Light Chain (AL) Amyloidosis | Oncology Today with Dr Neil Love: Amyloid Light Chain (AL) Amyloidosis (Companion Faculty Lecture)
|
Dec 06, 2022 |
|
Amyloid Light Chain (AL) Amyloidosis | Oncology Today with Dr Neil Love: Amyloid Light Chain (AL) Amyloidosis
|
Dec 06, 2022 |
|
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love — Novel Agents and Strategies in AML
|
Dec 05, 2022 |
|
Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 2
|
Dec 02, 2022 |
|
Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)
|
Dec 01, 2022 |
|
Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis
|
Dec 01, 2022 |
|
Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer
|
Nov 30, 2022 |
|
Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma (Companion Faculty Lecture)
|
Nov 29, 2022 |
|
Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma
|
Nov 29, 2022 |
|
Non-Small Cell Lung Cancer | Stephen V Liu, MD
|
Nov 28, 2022 |
|
Non-Small Cell Lung Cancer | John V Heymach, MD, PhD
|
Nov 28, 2022 |
|
Non-Small Cell Lung Cancer | Current Paradigm and Future Directions for Immunotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer
|
Nov 28, 2022 |
|
Breast Cancer | Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer — Part 3
|
Nov 22, 2022 |
|
Hepatocellular Carcinoma | Oncology Today with Dr Neil Love: Management of Hepatocellular Carcinoma (Companion Faculty Lecture)
|
Nov 21, 2022 |
|
Hepatocellular Carcinoma | Oncology Today with Dr Neil Love: Management of Hepatocellular Carcinoma
|
Nov 21, 2022 |
|
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Novel Agents and Strategies in AML
|
Nov 17, 2022 |
|
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Novel Agents and Strategies in AML (Companion Faculty Lecture)
|
Nov 17, 2022 |
|
Melanoma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Gastrointestinal Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Ovarian Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Endometrial Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Breast Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Hepatobiliary Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Multiple Myeloma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Renal Cell Carcinoma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Prostate and Bladder Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Lung Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
|
Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Higher-Risk Myelodysplastic Syndromes
|
Nov 15, 2022 |
|
Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Higher-Risk Myelodysplastic Syndromes (Companion Faculty Lecture)
|
Nov 15, 2022 |
|
Multiple Myeloma| BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 1
|
Nov 11, 2022 |
|
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences (Companion Faculty Lecture)
|
Nov 10, 2022 |
|
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences
|
Nov 10, 2022 |
|
Prostate Cancer | Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 1
|
Nov 09, 2022 |
|
Chronic Lymphocytic Leukemia | Challenging Cases from Junior Investigators: The Application of Available and Emerging Clinical Research in the Care of Patients with Chronic Lymphocytic Leukemia
|
Nov 08, 2022 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer (Companion Faculty Lecture)
|
Nov 07, 2022 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer
|
Nov 07, 2022 |
|
Myelofibrosis | Oncology Today with Dr Neil Love: Current Management of Myelofibrosis (Companion Faculty Lecture)
|
Nov 03, 2022 |
|
Myelofibrosis | Oncology Today with Dr Neil Love: Current Management of Myelofibrosis
|
Nov 03, 2022 |
|
Neuroendocrine Tumors | Oncology Today with Dr Neil Love: Neuroendocrine Tumors (Companion Faculty Lecture)
|
Nov 01, 2022 |
|
Neuroendocrine Tumors | Oncology Today with Dr Neil Love: Neuroendocrine Tumors
|
Nov 01, 2022 |
|
Non-Small Cell Lung Cancer | Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 3
|
Oct 31, 2022 |
|
Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 1
|
Oct 28, 2022 |
|
Melanoma | Oncology Today with Dr Neil Love: BRAF-Mutant Metastatic Melanoma
|
Oct 27, 2022 |
|
Melanoma | Oncology Today with Dr Neil Love: BRAF-Mutant Metastatic Melanoma (Companion Faculty Lecture)
|
Oct 27, 2022 |
|
Diffuse Large B-Cell Lymphoma | Challenging Cases from the Community: Investigators Provide Perspectives on the Optimal Management of Diffuse Large B-Cell Lymphoma
|
Oct 26, 2022 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of RET Fusion-Positive Non-Small Cell Lung Cancer (Companion Video Lecture)
|
Oct 25, 2022 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of RET Fusion-Positive Non-Small Cell Lung Cancer
|
Oct 25, 2022 |
|
Breast Cancer | Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer — Part 2
|
Oct 21, 2022 |
|
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Nonmetastatic Urothelial Bladder Cancer (Companion Faculty Lecture)
|
Oct 20, 2022 |
|
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Nonmetastatic Urothelial Bladder Cancer
|
Oct 20, 2022 |
|
Myelodysplastic Syndromes | Exploring Current Considerations and Promising Investigational Approaches for Patients with Myelodysplastic Syndromes
|
Oct 19, 2022 |
|
Small Cell Lung Cancer | Meet The Professor: Optimizing the Management of Small Cell Lung Cancer — Part 2
|
Oct 17, 2022 |
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 5
|
Oct 13, 2022 |
|
Head and Neck and Thyroid Cancers | Meet The Professor: Optimizing the Management of Head and Neck and Thyroid Cancers
|
Oct 11, 2022 |
|
Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Patients with Small Cell Lung Cancer
|
Oct 06, 2022 |
|
Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Patients with Small Cell Lung Cancer (Companion Faculty Lecture)
|
Oct 06, 2022 |
|
Oncology Today: Management of Endometrial Cancer
|
Oct 04, 2022 |
|
Multiple Myeloma | Oncology Today with Dr Neil Love: BCMA-Directed Therapies for Multiple Myeloma (Companion Faculty Lecture)
|
Sep 29, 2022 |
|
Multiple Myeloma | Oncology Today with Dr Neil Love: BCMA-Directed Therapies for Multiple Myeloma
|
Sep 29, 2022 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Localized Non-Small Cell Lung Cancer (Companion Faculty Lecture)
|
Sep 26, 2022 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Localized Non-Small Cell Lung Cancer
|
Sep 26, 2022 |
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4
|
Sep 23, 2022 |
|
Breast Cancer | Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer — Part 1
|
Sep 22, 2022 |
|
Non-Small Cell Lung Cancer | Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 2
|
Sep 20, 2022 |
|
Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Current and Future Management of Hodgkin Lymphoma (Companion Faculty Lecture)
|
Sep 15, 2022 |
|
Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Current and Future Management of Hodgkin Lymphoma
|
Sep 15, 2022 |
|
Interstitial Lung Disease | Oncology Today with Dr Neil Love: Interstitial Lung Disease in Patients Receiving Anticancer Therapy (Companion Faculty Lecture)
|
Sep 13, 2022 |
|
Interstitial Lung Disease | Oncology Today with Dr Neil Love: Interstitial Lung Disease in Patients Receiving Anticancer Therapy
|
Sep 13, 2022 |
|
Small Cell Lung Cancer | Meet The Professor: Optimizing the Management of Small Cell Lung Cancer — Part 1
|
Sep 09, 2022 |
|
Endometrial Cancer | Oncology Today with Dr Neil Love: Endometrial Cancer Edition (Companion Faculty Lecture)
|
Sep 08, 2022 |
|
Endometrial Cancer | Oncology Today with Dr Neil Love: Endometrial Cancer Edition
|
Sep 08, 2022 |
|
Gastroesophageal Cancers | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 5
|
Sep 07, 2022 |
|
Oncology Today with Dr Neil Love: Ocular Toxicities in Patients Receiving Anticancer Therapy (Companion Faculty Lecture)
|
Sep 06, 2022 |
|
Ocular Toxicities | Oncology Today with Dr Neil Love: Ocular Toxicities in Patients Receiving Anticancer Therapy
|
Sep 06, 2022 |
|
Non-Small Cell Lung Cancer | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 4
|
Sep 02, 2022 |
|
Hematologic Cancers | Data + Perspectives: Investigators Discuss the Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies in the Care of Patients with Hematologic Cancers
|
Sep 01, 2022 |
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3
|
Aug 31, 2022 |
|
Lung Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
|
Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
|
Multiple Myeloma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
|
Genitourinary Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
|
Breast Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
|
Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)
|
Aug 24, 2022 |
|
Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting
|
Aug 24, 2022 |
|
Gastrointestinal Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 18, 2022 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: KRAS-Mutant Non-Small Cell Lung Cancer (Companion Faculty Lecture)
|
Aug 18, 2022 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: KRAS-Mutant Non-Small Cell Lung Cancer
|
Aug 18, 2022 |
|
Hepatobiliary Cancers | Meet The Professor: Optimizing the Management of Hepatobiliary Cancers — Part 2
|
Aug 17, 2022 |
|
Gynecologic Cancers | Oncology Today with Dr Neil Love: Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)
|
Aug 16, 2022 |
|
Gynecologic Cancers | Oncology Today with Dr Neil Love: Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting
|
Aug 16, 2022 |
|
Gastroesophageal Cancers | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 4
|
Aug 10, 2022 |
|
Head, Neck and Thyroid Cancers | Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting
|
Aug 08, 2022 |
|
Head, Neck and Thyroid Cancers | Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)
|
Aug 08, 2022 |
|
Chronic Myeloid Leukemia | Meet The Professor: Optimizing the Management of Chronic Myeloid Leukemia — Part 2
|
Aug 04, 2022 |
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2
|
Aug 03, 2022 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in the Management of HER2-Low Breast Cancer
|
Aug 02, 2022 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in the Management of HER2-Low Breast Cancer (Companion Faculty Lecture)
|
Aug 02, 2022 |
|
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Unresectable Stage III Non-Small Cell Lung Cancer
|
Aug 01, 2022 |
|
Meet The Professor: Optimizing the Management of Hepatobiliary Cancers — Part 1
|
Jul 29, 2022 |
|
Genitourinary Cancers | Oncology Today with Dr Neil Love: Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting (Companion faculty lecture)
|
Jul 28, 2022 |
|
Genitourinary Cancers | Oncology Today with Dr Neil Love: Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting
|
Jul 28, 2022 |
|
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes – A Review of the 2022 ASCO Annual Meeting and EHA Congress
|
Jul 27, 2022 |
|
Hodgkin and Non-Hodgkin Lymphomas | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Hodgkin and Non-Hodgkin Lymphomas
|
Jul 22, 2022 |
|
Cholangiocarcinoma | Oncology Today with Dr Neil Love: Management of Cholangiocarcinoma and Other Biliary Tract Cancers
|
Jul 21, 2022 |
|
Cholangiocarcinoma | Oncology Today with Dr Neil Love: Management of Cholangiocarcinoma and Other Biliary Tract Cancers (Companion Faculty Lecture)
|
Jul 21, 2022 |
|
Chronic Myeloid Leukemia | Meet The Professor: Optimizing the Management of Chronic Myeloid Leukemia — Part 1
|
Jul 20, 2022 |
|
Non-Small Cell Lung Cancer | Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 1
|
Jul 19, 2022 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Key Presentations on Breast Cancer from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)
|
Jul 18, 2022 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Key Presentations on Breast Cancer from the 2022 ASCO Annual Meeting
|
Jul 18, 2022 |
|
Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 6
|
Jul 15, 2022 |
|
Prostate Cancer | Fred Saad, MD
|
Jul 14, 2022 |
|
Prostate Cancer | Johann S de Bono, MB ChB, MSc, PhD, FMedSci
|
Jul 14, 2022 |
|
Prostate Cancer | PARP Inhibition in the Management of Prostate Cancer — Where We Are and Where We're Headed
|
Jul 14, 2022 |
|
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1
|
Jul 13, 2022 |
|
Non-Small Cell Lung Cancer | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 3
|
Jul 12, 2022 |
|
Multiple Myeloma | Breakfast with the Investigators: Multiple Myeloma
|
Jul 11, 2022 |
|
Gastroesophageal Cancers | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3
|
Jul 08, 2022 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in HER2-Low Breast Cancer (Companion Faculty Lecture)
|
Jul 07, 2022 |
|
Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in HER2-Low Breast Cancer
|
Jul 07, 2022 |
|
Lung Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jul 06, 2022 |
|
Hematologic Oncology | Oncology Today with Dr Neil Love: Current and Future Management of Follicular Lymphoma (Companion Video Lecture)
|
Jul 05, 2022 |
|
Hematologic Oncology | Oncology Today with Dr Neil Love: Current and Future Management of Follicular Lymphoma
|
Jul 05, 2022 |
|
Urothelial Bladder Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 30, 2022 |
|
Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma| Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 29, 2022 |
|
Breast Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 28, 2022 |
|
Gastrointestinal Cancers| Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 27, 2022 |
|
Cervical and Endometrial Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 24, 2022 |
|
Ovarian Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 23, 2022 |
|
Prostate Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 22, 2022 |
|
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2
|
Jun 21, 2022 |
|
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 20, 2022 |
|
Gastroesophageal Cancers | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Gastroesophageal Cancers
|
Jun 17, 2022 |
|
Myelofibrosis | Meet The Professor: Current and Future Management of Myelofibrosis — Part 3
|
Jun 16, 2022 |
|
Chronic Lymphocytic Leukemia | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 14, 2022 |
|
Urothelial Bladder Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 13, 2022 |
|
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 10, 2022 |
|
Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 5
|
Jun 09, 2022 |
|
Small Cell Lung Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 07, 2022 |
|
Hepatobiliary Cancers | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Hepatobiliary Cancers
|
Jun 06, 2022 |
|
Renal Cell Carcinoma | Clinical Investigator Perspectives on the Management of Renal Cell Carcinoma (Faculty Presentation)
|
Jun 02, 2022 |
|
Renal Cell Carcinoma | Clinical Investigator Perspectives on the Management of Renal Cell Carcinoma
|
Jun 02, 2022 |
|
Acute Myeloid Leukemia | Striving for Consensus on the Management of Secondary Acute Myeloid Leukemia
|
May 31, 2022 |
|
Prostate Cancer | Proceedings from a live event held adjunct to the American Urological Association 2022 Annual Meeting
|
May 27, 2022 |
|
NSCLC | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 2
|
May 26, 2022 |
|
Bladder Cancer | Proceedings from a live event held adjunct to the American Urological Association 2022 Annual Meeting
|
May 25, 2022 |
|
Ovarian Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
May 24, 2022 |
|
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1
|
May 23, 2022 |
|
Non-Small Cell Lung Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
May 19, 2022 |
|
Breast Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
May 17, 2022 |
|
Prostate Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
May 12, 2022 |